Adapted physical activity for recovery after stem cell transplantation
APALLO : Post Allogeneic Stem Cell Transplantation Adapted Physical Activity for Patient With Hematological Malignancies
NA · Centre Hospitalier Universitaire de Nice · NCT05379738
This study tests if doing six sessions of adapted physical activity at home can help people recovering from stem cell transplants lose weight and improve their quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice (other) |
| Locations | 1 site (Nice) |
| Trial ID | NCT05379738 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of six sessions of adapted physical activity on patients recovering from allogeneic stem cell transplantation for hematological malignancies. Participants will engage in these sessions at home between one and three months post-transplant. The primary focus is to assess improvements in weight loss and quality of life resulting from this tailored physical activity program.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 or older who are scheduled for allogeneic stem cell transplantation and can provide informed consent.
Not a fit: Patients with significant additional physical or mental diseases, or those who develop incapacity to engage in physical activity, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and overall quality of life for patients undergoing stem cell transplantation.
How similar studies have performed: While similar approaches have been explored, this specific adaptation for post-stem cell transplantation recovery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria : * Patient aged 18 or more * Patient with social security * Patient who accept the study and sign the consent form * Patient programmed for an allogenic stem cell transplantation Non inclusion criteria : * Patients with a guardianship * Patients with a significant additional physic or mental disease Exclusion criteria * Patients who did not receive an allogeniac stem cell transplantation * Patients still hospitalized between day 30 and day 100 after stem cell transplantation * Patients who finally refuses the study * Patients who develop a physical or mental incapacity to practice physical activity
Where this trial is running
Nice
- CHU NICE, hopital ARCHET 1, hématologie — Nice, France (RECRUITING)
Study contacts
- Principal investigator: SOLDATI Alizée — CHU NICE, hopital ARCHET 1, hématologie
- Study coordinator: SOLDATI Alizée
- Email: soldati.a@chu-nice.fr
- Phone: 04 92 03 96 27
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Haematological Malignancy